Happy New Year and welcome to the first 2017 issue of our newsletter. The last quarter of 2016 was a very busy one for the group which saw us achieve some significant milestones. In particular, we are delighted to have opened two new trials, DREAM in mesothelioma and NIVORAD in advanced NSCLC. In October we held the 2nd ALTG Preceptorship in Lung Cancer, followed by the inaugural ALTG Lung Cancer Symposium in November: both were great successes and are clearly becoming the mainstays of our educational activities. The Lung Cancer Symposium was captured on video and we are looking at ways to disseminate the information further in the first half of this year – keep an eye out for a Member Update for this, as we will most likely use our website to make the videos available. Both the Preceptorship and Symposium will be hosted again in 2017 and our website is already updated with all of our key meeting dates for this year. To cap off a busy year, many of our members attended the 17th WCLC in early December. In the last 12 months our portfolio of active trials and concepts in development has grown substantially and in May we will hold the first of our 2017 Members’ Meetings, bringing the group together to update and review progress. Trials are our lifeblood so it’s important that we continue to build momentum and generate new ideas as research in the field continues to advance. We have chosen the Parkroyal Melbourne Airport as the venue and will develop an agenda that allows a “fly in, fly out” visit for east coast residents – I hope to see many of you there!